Gene · 2012
Papers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Substituent‑controlled energy‑sensitivity trade‑off in (E)-1,2-bis(tetrazolo[1,5-d][1,2,3,4]tetrazin-7(1H)-yl)diazene derivatives. | J Mol Model | 2026 | 42776264 | PubTator, text mining | PubMed |
| The Anisotropic Response and Initial Reaction Mechanism of a CL-20/MTNP High-Energy Cocrystal under Impact Loading. | ACS Omega | 2026 | 42730066 | PubTator, text mining | PubMed |
| Generalizable 3'-Hydroxyl-Regenerating Primer Platform for Photoactivatable DNA Polymerase Regulation in Nucleic Acid Amplification. | Anal Chem | 2026 | 42689565 | PubTator, text mining | PubMed |
| Physical Responses to the Structural Evolution of CL-20-Based Energetic Solvates with H2O2 and H2O Under External Electric Field. | Int J Mol Sci | 2026 | 42653214 | PubTator, text mining | PubMed |
| Pseudomorphic Replacement Driven Construction of Hierarchical Homostructured CL-20 Core-Shell Architectures for Safety Improvement. | Small | 2026 | 42522771 | PubTator, text mining | PubMed |
| Effect of Precompression on Detonation Performance and Products of Energetic Materials: Application to CL-20. | J Phys Chem C Nanomater Interfaces | 2026 | 42416200 | PubTator, text mining | PubMed |
| Correction: Expression analysis of epithelial membrane protein 1 (EMP1) gene in kidney stone patients. | Int Urol Nephrol | 2026 | 42405990 | PubTator, text mining | PubMed |
| Bridging local-global transmembrane protein contexts with contrastive pretraining for alignment-free pathogenicity prediction. | Brief Bioinform | 2026 | 42398071 | PubTator, text mining | PubMed |
| A Novel CAF-Related Signature for Precise Prediction of Clinical Outcomes and Immunotherapy Response for Breast Cancer Patients: Based on Multiomics Analyses and Experimental Validation. | Mediators Inflamm | 2026 | 42359574 | PubTator, text mining | PubMed |
| Preconditioning with sufentanil confers protective effects in transplantation by attenuating hepatic ischemia-reperfusion injury. | World J Transplant | 2026 | 42281863 | PubTator, text mining | PubMed |
| Expression analysis of epithelial membrane protein 1 (EMP1) gene in kidney stone patients. | Int Urol Nephrol | 2026 | 42271084 | PubTator, text mining | PubMed |
| Exploring the chemical and biological interplay in phenanthroline-containing copper complexes. | Biometals | 2026 | 42217117 | PubTator, text mining | PubMed |
| Exercise-related genes predicts overall survival and tumor immune microenvironment, and identifies the biological role of SLC52A2 in breast cancer. | Discov Oncol | 2026 | 42215809 | PubTator, text mining | PubMed |
| Analysis of the Kinetics of Folding and Insertion of β-Barrel Membrane Proteins by Gel-Electrophoresis. | Methods Mol Biol | 2026 | 42156676 | PubTator, text mining | PubMed |
| Dicyandiamide-Modified Ultrahighly Cross-Linked Polystyrene Resin for Selective CL-20 Adsorption from Explosive Waste Acid. | ACS Omega | 2026 | 42077908 | PubTator, text mining | PubMed |
| Molecular dynamics simulation of CL20/4-bromo-3,5-dinitro-1-methylpyrazole (BMDNP) eutectic-based PBXs. | J Mol Model | 2026 | 42043616 | PubTator, text mining | PubMed |
| Mechanism of the reduced shock sensitivity of CL-20/MTNP co-crystals from reactive molecular dynamics simulations. | RSC Adv | 2026 | 41983166 | PubTator, text mining | PubMed |
| Atomistic Insights into the Radiation-Induced Damage Mechanisms of CL-20: Effects on Shock Sensitivity and Detonation Performance. | J Phys Chem A | 2026 | 41955079 | PubTator, text mining | PubMed |
| Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBC. | Sci Adv | 2026 | 41931605 | PubTator, text mining | PubMed |
| Targeting Ferroptosis With Natural Products for the Treatment of Skeletal System Disease: An Updated Review. | J Cell Mol Med | 2026 | 41928432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2012/papers